Among them, NDUFV2, PPARGC1B and PFKFB4 were regarded as prognostic protective factors for ccRCC (HR < 1), and their high expression had a positive correlation with the survival and prognosis of patients. This evidence concerns the gene PFKFB4 and nonpapillary renal cell carcinoma.